Advanced search
Publication Cover
Patient Preference and Adherence Volume 14, 2020 - Issue
Submit an article Journal homepage
193
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Treatment Mode Preferences in Psoriatic Arthritis: A Qualitative Multi-Country Study

Daniel Aletaha1 Division of Rheumatology, Department of Internal Medicine 3, Medical University of Vienna, Vienna, AustriaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2108-0030View further author information
ORCID Icon,
M Elaine Husni2 Cleveland Clinic, Department of Rheumatic and Immunologic Diseases, Cleveland, OH, USAORCID Iconhttps://orcid.org/0000-0002-3181-4205View further author information
ORCID Icon,
Joseph F Merola3 Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USAView further author information
,
Roberto Ranza4 Serviço de Reumatología, Universidade Federal de Uberlândia, Uberlândia, Minas Gerais, BrazilView further author information
,
Heidi Bertheussen5 Patient Representative, Oslo, NorwayORCID Iconhttps://orcid.org/0000-0001-6693-9254View further author information
ORCID Icon,
Ralph Lippe6 Inflammation & Immunology, Pfizer Pharma GmbH, Berlin, GermanyView further author information
,
Pamela M Young7 Inflammation & Immunology, Pfizer Inc, Collegeville, PA, USAView further author information
,
Joseph C Cappelleri8 Statistics, Pfizer Inc, Groton, CT, USAORCID Iconhttps://orcid.org/0000-0001-9586-0748View further author information
ORCID Icon,
T Michelle Brown9 RTI Health Solutions, Research Triangle Park, NC, USAView further author information
,
Claire Ervin9 RTI Health Solutions, Research Triangle Park, NC, USAView further author information
,
Ming-Ann Hsu10 Health Economics & Outcomes Research, Pfizer Inc, Groton, CT, USAView further author information
&
Lara Fallon11 Medical Affairs, Pfizer Inc, Montreal, QC, CanadaView further author information
 show all
Pages 949-961 | Published online: 08 Jun 2020

References

  • Helliwell P, Coates L, Chandran V, et al. Qualifying unmet needs and improving standards of care in psoriatic arthritis. Arthritis Care Res. 2014;66(12):1759–1766. doi:10.1002/acr.22404
  • Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med. 2017;17(1):65–70. doi:10.7861/clinmedicine.17-1-65
  • Lee S, Mendelsohn A, Sarnes E. The burden of psoriatic arthritis: a literature review from a global health systems perspective. Pharm Ther. 2010;35(12):680–689.
  • Kaine J, Song X, Kim G, Hur P, Palmer JB. Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using U.S. administrative claims data. J Manage Care Spec Pharm. 2019;25(1):122–132. doi:10.18553/jmcp.2018.17421
  • Coates LC, Kavanaugh A, Mease PJ, et al. Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016;68(5):1060–1071. doi:10.1002/art.39573
  • Gossec L, Smolen JS, Ramiro S, et al. European league against rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75(3):499–510. doi:10.1136/annrheumdis-2015-208337
  • Singh JA, Guyatt G, Ogdie A, et al. Special article: 2018 American college of rheumatology/national psoriasis foundation guideline for the treatment of psoriatic arthritis. Arthritis Care Res (Hoboken). 2019;71(1):2–29. doi:10.1002/acr.23789
  • Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957–970. doi:10.1056/NEJMra1505557
  • Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73(1):6–16. doi:10.1136/annrheumdis-2013-203419
  • Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189–199.
  • Betteridge N, Boehncke WH, Bundy C, Gossec L, Gratacós J, Augustin M. Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience. J Eur Acad Dermatol Venereol. 2016;30(4):576–585. doi:10.1111/jdv.13306
  • Chastek B, Fox KM, Watson C, Gandra SR. Etanercept and adalimumab treatment patterns in psoriatic arthritis patients enrolled in a commercial health plan. Adv Ther. 2012;29(8):691–697. doi:10.1007/s12325-012-0039-3
  • Saad AA, Ashcroft DM, Watson KD, Hyrich KL, Noyce PR, Symmons DP. Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British society of rheumatology biologics register. Arthritis Res Ther. 2009;11(2):R52. doi:10.1186/ar2670
  • Xu Y, Sudharshan L, Hsu MA, et al. Patient preferences associated with therapies for psoriatic arthritis: a conjoint analysis. Am Health Drug Benefits. 2018;11(8):408–417.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa
  • SAS Proprietary Software, Version 9.4 [Computer Program]. Cary NC:SAS Institute Inc.
  • Rosner B. Fundamentals of Biostatistics. 8th ed. Boston, MA: Cengage Learning; 2015.
  • Louder AM, Singh A, Saverno K, et al. Patient preferences regarding rheumatoid arthritis therapies: a conjoint analysis. Am Health Drug Benefits. 2016;9(2):84–93.
  • Taylor PC, Betteridge N, Brown TM, et al. Treatment mode preferences in rheumatoid arthritis: moving toward shared decision-making. Patient Prefer Adherence. 2020;14:119–131. doi:10.2147/PPA.S220714
  • Scarpato S, Antivalle M, Favalli EG, et al. Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). Rheumatology (Oxford). 2010;49(2):289–294. doi:10.1093/rheumatology/kep354

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.